Evaluation of the Efficacy of Electroacupuncture in the Treatment of Chronic Atrophic Gastritis

Exclusion Criteria

• •Autoimmune gastritis (type A chronic atrophic gastritis);
• •Participants with a positive C-13 urea breath test at baseline (Helicobacter pylori infection);
• •Patients diagnosed with high-grade intraepithelial neoplasia based on upper gastrointestinal endoscopy and gastric mucosal biopsy pathology;
• •Patients with confirmed or unresolved malignant tumours, particularly oesophageal cancer and gastric cancer; patients with other upper gastrointestinal lesions such as peptic ulcers or Barrett's oesophagus;
• •Patients with severe lesions in major organs (heart, liver, kidney, lung, etc.) or other autoimmune diseases (rheumatic diseases, Crohn's disease, autoimmune pancreatitis, etc.); Persons with cardiac pacemakers;
• •Pregnant and lactating women;
• •Patients with infectious diseases such as tuberculosis, hepatitis, or HIV/AIDS;
• •Individuals with a history of alcohol abuse, drug use, or illicit drug use;
• •Individuals who have used other prokinetic agents, mucosal protectants, acid-suppressing medications, or related traditional Chinese medicines within the past two weeks;
• •Individuals currently participating in or who have participated in other clinical trials within the past two months; individuals unable to tolerate acupuncture or with contraindications for acupuncture treatment; and individuals deemed unsuitable for participation in this clinical trial by the research team.